Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients with Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-label, Registration Directed Phase 2 Study

Drug Category : Array
Conference Category : Array
Lead Author : Fowler N, et al.
Published Date : 04/06/2019
Download Link : https://www.tgtherapeutics.com/ASCO%202019%20MZL%20Deck%20FINAL.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top